Qingzhou K. Guan

Collaborative Innovation Center For Chinese Medicine And Respiratory Diseases By Henan And Education Ministry Of P.R. China, Henan Key Laboratory Of Chinese Medicine For Respiratory Disease
Zhengzhou, 450046, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Effective-Component Compatibility of Bufei Yishen Formula III Improves Chronic Obstructive Pulmonary Disease by Inhibiting Inflammatory Responses Through Blocking PTX3 Activation.

Effective-Component Compatibility of Bufei Yishen Formula III Improves Chronic Obstructive Pulmonary Disease by Inhibiting Inflammatory Responses Through Blocking PTX3 Activation.

Journal: Journal of inflammation research

Published: April 01, 2026

Screening biomarkers for diagnosis of COPD by multiplex-high-resolution mass spectrometry based pseudotargeted lipidomics.

Screening biomarkers for diagnosis of COPD by multiplex-high-resolution mass spectrometry based pseudotargeted lipidomics.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: July 09, 2025

Exploring the Intervention Mechanism of Effective-Component Combination of Bufei Yishen Formula III for Airway Epithelial Barrier Injury: A miRNA-mRNA Regulatory Network Analysis.

Exploring the Intervention Mechanism of Effective-Component Combination of Bufei Yishen Formula III for Airway Epithelial Barrier Injury: A miRNA-mRNA Regulatory Network Analysis.

Journal: Journal of inflammation research

Published: March 21, 2025

Integrating single-cell analysis and machine learning to identify COPD hub genes and explore the intervention mechanism of effective component compatibility of Bufei Yishen formula III.

Integrating single-cell analysis and machine learning to identify COPD hub genes and explore the intervention mechanism of effective component compatibility of Bufei Yishen formula III.

Journal: Journal of ethnopharmacology

Published: February 14, 2025

Mechanism of effective-component compatibility of Bufei Yishen formula Ⅲ in COPD and identification of hub genes.

Mechanism of effective-component compatibility of Bufei Yishen formula Ⅲ in COPD and identification of hub genes.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: January 26, 2025

Temporal trends and attributable risk factors of chronic kidney disease burden in Fujian Province, 1990-2019

Temporal trends and attributable risk factors of chronic kidney disease burden in Fujian Province, 1990-2019

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: January 19, 2025

Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease.

Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease.

Journal: Annals of medicine

Published: September 14, 2024

Identification of idiopathic pulmonary fibrosis hub genes and exploration of the mechanisms of action of Jinshui Huanxian formula.

Identification of idiopathic pulmonary fibrosis hub genes and exploration of the mechanisms of action of Jinshui Huanxian formula.

Journal: International immunopharmacology

Published: February 19, 2024

Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.

Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.

Journal: Chinese medicine

Published: September 23, 2023

Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis-related genes and potential therapeutic drugs.

Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis-related genes and potential therapeutic drugs.

Journal: BMC pulmonary medicine

Published: April 19, 2023

Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.

Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 12, 2023

Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes.

Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes.

Journal: Annals of medicine

Published: August 22, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026